Sort by
Refine Your Search
-
nationalities represented in a student body of 43,800 students. Our main location in Central London has recently been augmented by a campus on the Queen Elizabeth Olympic Park. The UCL Faculty of Engineering is
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
. This role is eligible for hybrid working with a minimum of 60% of time on site. For a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs ) and
-
About us The Faculty of Life Sciences (FLS) at UCL combines the strengths of UCL's basic biological and preclinical sciences and is associated with 11 Nobel Laureates. Research in FLS focuses
-
. The UCL GOS ICH, together with its clinical partner Great Ormond Street Hospital for Children, forms the largest concentration of children’s health research outside North America. The 2024-29 GOS ICH
-
11 Nov 2025 Job Information Organisation/Company Newcastle University Research Field Medical sciences » Medicine Researcher Profile Established Researcher (R3) Country United Kingdom Application